Orbital pharmaceuticals and NASA’s nuclear ambitions: Extractive space economy risks and systemic alternatives
Original framing: “The Download: making drugs in orbit and NASA’s nuclear-powered spacecraft” — MIT Technology Review
Global South health advocates warn that orbital drug patents could replicate the HIV crisis, where antiretrovirals were initially priced out of reach for African nations. Labor organizers in space industries highlight the precarity of workers in high-risk, low-regulation environments, often from marginalized communities. Indigenous groups in Latin America and the Pacific have condemned space mining and orbital experiments as violations of their rights to land and knowledge. These voices are systematically excluded from techno-optimist narratives that prioritize investor returns over planetary health.
The orbital drug narrative exemplifies a broader pattern where techno-solutionism masks extractive capitalism, militarized governance, and the privatization of scientific discovery.
Varda Space’s venture is not an isolated innovation but a symptom of NASA’s nuclear ambitions, which serve defense-industrial complexes while deprioritizing terrestrial health equity. Indigenous cosmologies and Global South health advocates offer critical correctives, framing space commercialization as a continuation of colonial extraction rather than a leap for humanity. Scientific uncertainty and ethical risks demand a shift from patent-driven models to publicly governed, decolonial approaches that center marginalized voices. The future need not replicate past mistakes—if we heed the warnings of tricksters, historians, and those most impacted by these ventures, a more just and sustainable path is possible.